首页 | 本学科首页   官方微博 | 高级检索  
     

他汀类药物抗脓毒症作用研究进展
引用本文:詹剑勇,霍正禄. 他汀类药物抗脓毒症作用研究进展[J]. 中国急救医学, 2008, 28(11): 1030-1032
作者姓名:詹剑勇  霍正禄
作者单位:解放军第二军医大学附属长海医院急诊科,上海,200433
摘    要:脓毒症的发病率正日益增加,目前仍是临床危重症患者的主要死因.越来越多的临床观察研究和基础研究表明,他汀类药物有可能降低脓毒症患者的病死率,其作用机制包括抗炎、抗氧化、免疫调节、改善内皮功能、降低血液的凝血活性及增加NO的生物利用度等.然而,他汀类药物能否广泛应用于脓毒症治疗仍有待于在将来的临床试验中得到进一步验证.

关 键 词:他汀类药物  HMG-CoA还原酶抑制剂  脓毒症

Study of statins in anti-sepsis
ZHAN Jian-yong,HUO Zheng-lu. Study of statins in anti-sepsis[J]. Chinese Journal of Critical Care Medicine, 2008, 28(11): 1030-1032
Authors:ZHAN Jian-yong  HUO Zheng-lu
Affiliation:ZHAN Jian-yong,HUO Zheng-lu.Emergency Department,Changhai Hospital,the Second Military Medical University,PLA,Shanghai 200433,China
Abstract:The incidence of sepsis is increasing and remains the leading cause of death in critically ill patients.Evidences emerge from observational studies and basic science research that statins might be associated with reduced mortality in sepsis.Its potential mechanisms include antiinflammation and antioxidation,immunoregulation,improvement in endothelial function,reduction in blood thrombogenicity and increased nitric oxide (NO) bioavailability.However,the available evidence today suggests that the potential fo...
Keywords:Statins  HMG-CoA reductase inhibitor  Sepsis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号